words-of-wisdom
There is a peculiar character associated with approaching the finish line. Something goes wrong. For those fresh entrepreneurs in the throes of company construction, here is a rule that I have always (almost always) found true. As you get very close to the completion of a deal, something will appear that seemingly derails it. It could […]
Read More
December 27, 2010 source: (Bloomberg) Washington Post Nat Goldhaber, managing director of Claremont Creek Ventures, discusses Tesla Motors Inc.’s performance, its battery technology and the outlook for the electric-car market. Tesla, an unprofitable electric-automobile maker, fell the most since July after insiders were allowed to sell shares in the company. Goldhaber talks with Pimm Fox […]
Read MoreRecent media articles have scrutinized the use of doctors, scientists and experts by pharmaceutical companies and hedge funds, often casting them in an unflattering light. Experts can play a valuable role, but it is a case of caveat emptor – and sometimes for the expert, as well as the organization hiring him. Biotech or medical […]
Read MoreIt’s the end of the year – an opportune time to forecast how 2011 will unfold in health care. We are likely to see some surprises, such as the sharply rising importance of primary care physicians. Here are some predictions about the new year: More consolidation is on its way in healthcare under Obamacare, which […]
Read MoreI was at an event with a group of MBA students a couple of weeks ago, chatting with two of them. One asked me how the venture deal flow was different in the past. I made the off-hand comment that the World of Could seemed to have grown much bigger, but the World of Should […]
Read MoreLiving in the San Francisco Bay Area means that many of my friends are either entrepreneurs or work at start-ups. It’s a culture that we breathe here. Optimism and ideas. Makers and inventors. So when I was given the opportunity to be a judge in the Semi-Finals of the Intel + UC Berkeley Technology Entrepreneurship […]
Read MoreMeet our team
Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.
NAT GOLDHABER
Nat Goldhaber is a co-founder of Claremont Creek Ventures.
BRAD WEBB
Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.
RANDY HAWKS
Randy Hawks is a co-founder of Claremont Creek Ventures.